SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Jonatan Barrera Chimal
(Instituto de Investigaciones Biomédicas, Dirección General de Asuntos del Personal Académico)

Obras con ISBN:0
Documentos en revistas:56
Colaboraciones en Tesis:3
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- The mineralocorticoid receptor in chronic kidney disease (2022)
 
2.- Hepatocyte growth factor reverses cholemic nephropathy associated with alpha-naphthylisothiocyanate-induced cholestasis in mice (2022)
 
3.- Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease (2022)
 
4.- Editorial: Targeting Dysregulated Inflammation to Treat Cardiovascular Diseases (2022)
 
5.- The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease (2022)
 
6.- Mineralocorticoid receptor antagonists in diabetic kidney disease ? mechanistic and therapeutic effects (2022)
 
7.- Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases (2022)
 
8.- Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics (2021)
 
9.- Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy (2021)
 
10.- Editorial: Kidney and Distant Organ Crosstalk in Health and Disease (2021)
 
11.- Chronic Kidney Disease Induced by Cisplatin, Folic Acid and Renal Ischemia Reperfusion Induces Anemia and Promotes GATA-2 Activation in Mice (2021)
 
12.- DELETION AND BLOCKAGE OF KININ B1 RECEPTOR EXACERBATES CISPLATIN-INDUCED CKD (2021)
 
13.- Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism (2021)
 
14.- Oxidized albumin as a mediator of kidney disease (2021)
 
15.- MR (Mineralocorticoid Receptor) in Endothelial Cells: A Major Contributor in Pulmonary Arterial Hypertension Remodeling (2021)
 
16.- THE IMPORTANCE OF PPAR-ALPHA IN AKI TO CKD TRANSITION IN NEPHROPATHY INDUCED BY FOLIC ACID (2020)
 
17.- Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets (2020)
 
18.- Vascular and inflammatory mineralocorticoid receptors in kidney disease (2020)
 
19.- HGF induces protective effects in a-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress (2020)
 
20.- Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4 (2020)
 
21.- Ppar-a deletion attenuates cisplatin nephrotoxicity by modulating renal organic transporters mate-1 and oct-2 (2020)
 
22.- Resilience to acute kidney injury in offspring of maternal protein restriction (2019)
 
23.- Emerging therapeutic strategies for transplantation-induced acute kidney injury: protecting the organelles and the vascular bed (2019)
 
24.- HGF protector effect in intrahepatic cholestasis (2019)
 
25.- Randomized Controlled Trial Of Spironolactone Effect In Kidney Transplant Recipients Of Living Donors. (2019)
 
26.- Reduced endothelial nitric oxide synthase activation contributes to cardiovascular injury during chronic kidney disease progression (2019)
 
27.- Spironolactone reduces oxidative stress in living donor kidney transplantation: A randomized controlled trial (2019)
 
28.- Vascular mineralocorticoid receptor activation and disease (2019)
 
29.- Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation (2019)
 
30.- Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis (2019)
 
31.- The absence of endothelial sodium channel a (aENaC) reduces renal ischemia/reperfusion injury (2019)
 
32.- The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway (2018)
 
33.- The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling (2018)
 
34.- Short- and long-term administration of the non-steroidal mineralocorticoid receptor antagonist finerenone opposes metabolic syndrome-related cardio-renal dysfunction (2018)
 
35.- Myeloid Mineralocorticoid Receptor Controls Inflammatory and Fibrotic Responses After Renal Ischemic Injury via Macrophage Interleukin-4 Receptor. (2017)
 
36.- Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy (2017)
 
37.- Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease Role of Oxidative Stress (2017)
 
38.- Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1 (2017)
 
39.- HSP72 is an early biomarker to detect cisplatin and acetaminophen nephrotoxicity (2017)
 
40.- Sub-chronic exposure to fluoride impacts the response to a subsequent nephrotoxic treatment with gentamicin (2016)
 
41.- AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease (2016)
 
42.- Mineralocorticoid Receptor Antagonism: A Promising Therapeutic Approach to Treat Ischemic AKI (2016)
 
43.- Sulfenic acid modification of endothelin b receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia (2016)
 
44.- Hsp72 Is a Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients (2014)
 
45.- Tubular urinary biomarkers do not identify aetiology of acute kidney injury in kidney transplant recipients (2014)
 
46.- Early involvement of oxidative stress in the progression of chronic kidney disease induced by an acute kidney injury episode (2014)
 
47.- Urinary neutrophil gelatinase-associated lipocalin predicts graft loss after acute kidney injury in kidney transplant (2014)
 
48.- Intra-renal transfection of heat shock protein 90 alpha or beta (Hsp90a or Hsp90ß) protects against ischemia/reperfusion injury (2014)
 
49.- Proximal renal tubular injury in rats sub-chronically exposed to low fluoride concentrations (2013)
 
50.- The authors reply (2013)
 
51.- Losartan retards the development of Chronic Kidney Disease (CKD) after an Acute Kidney Injury (AKI) episode (2013)
 
52.- Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: A double-blind, randomized pilot study (2013)
 
53.- Recovery from ischemic acute kidney injury by spironolactone administration (2012)
 
54.- Gene Expression Analysis Reveals the Cell Cycle and Kinetochore Genes Participating in Ischemia Reperfusion Injury and Early Development in Kidney (2011)
 
55.- Hsp72 is an early and sensitive biomarker to detect acute kidney injury (2011)
 
56.- Opposite Effect of Hsp90 alpha and Hsp90 beta on eNOS Ability to Produce Nitric Oxide or Superoxide Anion in Human Embryonic Kidney Cells (2010)
 
Colaboraciones en Tesis:
1.- Efecto de la depleción de linfocitos T CD4+ sobre las alteraciones cardiovasculares en un modelo de enfermedad renal crónica (2021)
 
2.- Regulación de la vía de señalización de la sintasa de óxido nítrico endotelial por el canal epitelial de sodio en células endoteliales (2020)
 
3.- Caracterización de alteraciones cardíacas en un modelo de enfermedad renal crónica inducida por lesión renal aguda (2017)
 
Patentes:No hay patentes de este autor.